Abstract
Alternative pre-mRNA splicing occurs extensively in the nervous systems of complex organisms, including humans, considerably expanding the potential size of the proteome. Cell-specific alternative pre-mRNA splicing is thought to optimize protein function for specialized cellular tasks, but direct evidence for this is limited. Transmission of noxious thermal stimuli relies on the activity of N-type CaV2.2 calcium channels in nociceptors. Using an exon-replacement strategy in mice, we show that mutually exclusive splicing patterns in the CaV2.2 gene modulate N-type channel function in nociceptors, leading to a change in morphine analgesia. Exon 37a (e37a) enhances μ-opioid receptor–mediated inhibition of N-type calcium channels by promoting activity-independent inhibition. In the absence of e37a, spinal morphine analgesia is weakened in vivo but the basal response to noxious thermal stimuli is not altered. Our data suggest that highly specialized, discrete cellular responsiveness in vivo can be attributed to alternative splicing events regulated at the level of individual neurons.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lipscombe, D. Neuronal proteins custom designed by alternative splicing. Curr. Opin. Neurobiol. 15, 358–363 (2005).
Li, Q., Lee, J.A. & Black, D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 8, 819–831 (2007).
Ule, J. & Darnell, R.B. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16, 102–110 (2006).
Pan, Q., Shai, O., Lee, L.J., Frey, B.J. & Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413–1415 (2008).
Dredge, B.K., Polydorides, A.D. & Darnell, R.B. The splice of life: alternative splicing and neurological disease. Nat. Rev. Neurosci. 2, 43–50 (2001).
Mu, Y., Otsuka, T., Horton, A.C., Scott, D.B. & Ehlers, M.D. Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors. Neuron 40, 581–594 (2003).
Raingo, J., Castiglioni, A.J. & Lipscombe, D. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat. Neurosci. 10, 285–292 (2007).
Chen, M. & Manley, J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741–754 (2009).
Hille, B. Ion Channels of Excitable Membranes (Sinauer, Sunderland, Massachusetts, USA, 2001).
Xie, J. & Black, D.L.A. CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature 410, 936–939 (2001).
Mich, P.M. & Horne, W.A. Alternative splicing of the Ca2+ channel β4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking. Mol. Pharmacol. 74, 904–912 (2008).
Liao, P., Zhang, H.Y. & Soong, T.W. Alternative splicing of voltage-gated calcium channels: from molecular biology to disease. Pflugers Arch. 458, 481–487 (2009).
Zhong, X., Liu, J.R., Kyle, J.W., Hanck, D.A. & Agnew, W.S. A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum. Mol. Genet. 15, 1497–1512 (2006).
Bourinet, E. et al. Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat. Neurosci. 2, 407–415 (1999).
Adams, P.J. et al. CaV2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin) 3, 110–121 (2009).
Bell, T.J., Thaler, C., Castiglioni, A.J., Helton, T.D. & Lipscombe, D. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41, 127–138 (2004).
Castiglioni, A.J., Raingo, J. & Lipscombe, D. Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels. J. Physiol. (Lond.) 576, 119–134 (2006).
Altier, C. et al. Differential role of N-type calcium channel splice isoforms in pain. J. Neurosci. 27, 6363–6373 (2007).
Pan, J.Q. & Lipscombe, D. Alternative splicing in the cytoplasmic II–III loop of the N-type Ca channel α1B subunit: functional differences are β subunit-specific. J. Neurosci. 20, 4769–4775 (2000).
Nelson, M.T., Joksovic, P.M., Perez-Reyes, E. & Todorovic, S.M. The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J. Neurosci. 25, 8766–8775 (2005).
Taddese, A., Nah, S.Y. & McCleskey, E.W. Selective opioid inhibition of small nociceptive neurons. Science 270, 1366–1369 (1995).
Scherrer, G. et al. Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137, 1148–1159 (2009).
Glaum, S.R., Miller, R.J. & Hammond, D.L. Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14, 4965–4971 (1994).
Bao, J., Li, J.J. & Perl, E.R. Differences in Ca2+ channels governing generation of miniature and evoked excitatory synaptic currents in spinal laminae I and II. J. Neurosci. 18, 8740–8750 (1998).
Williams, J.T., Christie, M.J. & Manzoni, O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299–343 (2001).
Wilson, S.G. & Mogil, J.S. Measuring pain in the (knockout) mouse: big challenges in a small mammal. Behav. Brain Res. 125, 65–73 (2001).
Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77–88 (1988).
Hylden, J.L. & Wilcox, G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67, 313–316 (1980).
Wang, Y.X., Pettus, M., Gao, D., Phillips, C. & Scott Bowersox, S. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain. Pain 84, 151–158 (2000).
Marker, C.L., Lujan, R., Loh, H.H. & Wickman, K. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of μ- and δ- but not κ-opioids. J. Neurosci. 25, 3551–3559 (2005).
Costigan, M., Scholz, J. & Woolf, C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 32, 1–32 (2009).
Bowersox, S.S. et al. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279, 1243–1249 (1996).
Altier, C. & Zamponi, G.W. Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol. Sci. 25, 465–470 (2004).
Scott, D.A., Wright, C.E. & Angus, J.A. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur. J. Pharmacol. 451, 279–286 (2002).
Matthews, E.A. & Dickenson, A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 92, 235–246 (2001).
Malmberg, A.B. & Yaksh, T.L. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60, 83–90 (1995).
Saegusa, H., Matsuda, Y. & Tanabe, T. Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. Neurosci. Res. 43, 1–7 (2002).
Hille, B. et al. Multiple G-protein-coupled pathways inhibit N-type Ca channels of neurons. Life Sci. 56, 989–992 (1995).
Tedford, H.W. & Zamponi, G.W. Direct G protein modulation of Cav2 calcium channels. Pharmacol. Rev. 58, 837–862 (2006).
Elmslie, K.S. Neurotransmitter modulation of neuronal calcium channels. J. Bioenerg. Biomembr. 35, 477–489 (2003).
Kammermeier, P.J., Ruiz-Velasco, V. & Ikeda, S.R. A voltage-independent calcium current inhibitory pathway activated by muscarinic agonists in rat sympathetic neurons requires both Gαq/11 and Gβγ. J. Neurosci. 20, 5623–5629 (2000).
Shapiro, M.S. & Hille, B. Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathways. Neuron 10, 11–20 (1993).
Luebke, J.I. & Dunlap, K. Sensory neuron N-type calcium currents are inhibited by both voltage-dependent and -independent mechanisms. Pflugers Arch. 428, 499–507 (1994).
Ikeda, S.R. & Dunlap, K. Calcium channels diversify their signaling portfolio. Nat. Neurosci. 10, 269–271 (2007).
Ikeda, S.R. & Dunlap, K. Voltage-dependent modulation of N-type calcium channels: role of G protein subunits. Adv. Second Messenger Phosphoprotein Res. 33, 131–151 (1999).
Zhang, C. et al. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 22, 2550–2563 (2008).
Licatalosi, D.D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464–469 (2008).
Boutz, P.L. et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 21, 1636–1652 (2007).
Silverman, J.D. & Kruger, L. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J. Neurocytol. 19, 789–801 (1990).
Nagy, J.I. & Hunt, S.P. Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin. Neuroscience 7, 89–97 (1982).
Acknowledgements
We thank J. Kysik and E. Paul in the mouse transgenic facility at Brown University, R. Burwell for advice on animal behavior, T.D. Helton for help with image analyses and C.G. Phillips and S.E. Allen for helpful comments on the manuscript. This work was supported by US National Institutes of Health grants RO1NS055251 (D.L.), F31NS066702 (S.M.) and P20RR015578 (Transgenic Facility at Brown University).
Author information
Authors and Affiliations
Contributions
All authors contributed to writing this manuscript. A.A. carried out electrophysiological studies, S.D. designed targeting constructs and generated all exon-substituted mice, Y.-Q.J. performed the behavioral studies and immunohistochemistry, S.M. performed western analyses, and D.L. directed the project and oversaw all analyses.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–5, Supplementary Tables 1 and 2, Supplementary Methods (PDF 539 kb)
Rights and permissions
About this article
Cite this article
Andrade, A., Denome, S., Jiang, YQ. et al. Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing. Nat Neurosci 13, 1249–1256 (2010). https://doi.org/10.1038/nn.2643
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2643
This article is cited by
-
The role of specific isoforms of CaV2 and the common C-terminal of CaV2 in calcium channel function in sensory neurons of Aplysia
Scientific Reports (2023)
-
Critical Pronociceptive Role of Family 2 Voltage-Gated Calcium Channels in a Novel Mouse Model of HIV-Associated Sensory Neuropathy
Molecular Neurobiology (2023)
-
Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways
Pflügers Archiv - European Journal of Physiology (2022)
-
Opioid Receptor Regulation of Neuronal Voltage-Gated Calcium Channels
Cellular and Molecular Neurobiology (2021)
-
Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors
Molecular Brain (2019)